Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies
Dr. Alex Menze and Dr. Divyanshu Dubey discuss the clinical insights into autoimmune nodopathies, particularly focusing on CASPR1 and CASPR1/CNTN1-complex-IgG. Show citation: Paramasivan NK, Basal E…
Read the full articleYou might also wanna read
Resetting autoimmune disease with CAR cell therapies
Explore the potential of CAR T cells in autoimmune diseases: a novel way to target B cells, reset immunity, and meet clinical gaps! PMID:421
Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency
Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical imp
Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies
BACKGROUND Anti-nephrin autoantibodies have emerged as a putative pathogenic driver in a subset of patients with podocytopathies, including
Nephrin autoimmunity: signal, noise, and a path to clarity
Advances in antigen discovery and autoantibody profiling have reshaped the classification of autoimmune kidney diseases, moving beyond purel
Comments
Sign in to join the conversation.
No comments yet. Be the first.